It will one day be possible to carry out tests of new drugs on bacteria using microfluidic devices.
During the recent yellow fever outbreak in Africa, an enormous population was at risk, but the emergency vaccine stockpile held only six million doses of vaccine.
Researchers mapped all US Food and Drug Administration (FDA) licensed drugs and their mechanisms of action to identify new areas of research for future treatments.
An AI program may help in the search for new drug compounds.
Researchers are investigating how bacteria communicate with each other and how interrupting this communication could lead to decreased drug resistance.
The US Department of Health and Human Service (HHS) is working on technology to determine genetic code within four hours to facilitate a faster response to pandemic influenza and antibiotic-resistant infections.
A computer-based screening method could reveal the potential virus-fighting capability of drugs originally developed to treat other conditions.
Researchers tested the ability of pellets to synthesize a diphtheria vaccine. They found that the pellet-made vaccine elicited a protective response that was comparable to a traditional vaccine.
A computer-based screening method may be able to identify the virus-fighting potential of drugs originally developed to treat other conditions.
Efforts to align a disease-specific drug or vaccine with an emerging pandemic threat is difficult and often not successful.